 Connection
Susan Smyth to Purinergic P2Y Receptor Antagonists
This is a "connection" page, showing publications Susan Smyth has written about Purinergic P2Y Receptor Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.218 |
|
|
|
-
Xiang B, Zhang G, Ren H, Sunkara M, Morris AJ, Gartner TK, Smyth SS, Li Z. The P2Y(12) antagonists, 2MeSAMP and cangrelor, inhibit platelet activation through P2Y(12)/G(i)-dependent mechanism. PLoS One. 2012; 7(12):e51037.
Score: 0.116
-
Abo-Aly M, George B, Shokri E, Chelvarajan L, El-Helw M, Smyth SS, Abdel-Latif A, Ziada K. Cangrelor in addition to standard therapy reduces cardiac damage and inflammatory markers in patients with ST-segment elevation myocardial infarction. J Thromb Thrombolysis. 2021 Oct; 52(3):934-940.
Score: 0.050
-
Granada JF, Price MJ, French PA, Steinhubl SR, Cutlip DE, Becker RC, Smyth SS, Dauerman HL. Platelet-mediated thrombosis and drug-eluting stents. Circ Cardiovasc Interv. 2011 Dec 01; 4(6):629-37.
Score: 0.027
-
Dong A, Caicedo J, Han SG, Mueller P, Saha S, Smyth SS, Gairola CG. Enhanced platelet reactivity and thrombosis in Apoe-/- mice exposed to cigarette smoke is attenuated by P2Y12 antagonism. Thromb Res. 2010 Oct; 126(4):e312-7.
Score: 0.024
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|